The global infectious disease diagnostics market is expected to rise at a CAGR of 7.2 percent from USD 28.1 billion in 2021 to USD 39.8 billion in 2026. The global incidence of infectious diseases and the emergence of COVID-19, as well as rising awareness for early disease identification, a shift in focus from centralised laboratories to distributed POC testing, and technical improvements, are driving market expansion. Infectious disease prevalence in both established and developing nations will boost the infectious disease diagnostics market's growth. The rising number of prescriptions for infectious disease diagnostic tests is due to the diagnosis and management of such disorders. During the projection period, these factors, combined with the growing tendency toward preventative care, are projected to increase demand for infectious disease diagnostics.
Title : Ultrasound for diagnosing pneumonia. The place of the BLUE-protocol
Daniel A. Lichtenstein, Ambroise Pare Hospital, France
Title : Comparison between conventional endotracheal tubes and polymer-coated tubes in the development of ventilator-associated pneumonia: A systematic review and meta-analysis
Oscar Inacio, Universidade Federal de Campina Grande, Brazil
Title : Clinical significance and global burden of antibiotic resistance
Reza Nassiri, Michigan State University, United States
Title : Virus/mutation-agnostic vaccines
De chu Christopher Tang, VaxDome Inc., United States
Title : Antibiotic resistance of Enterococcus spp. strains isolated from wild and farm animals - an important non-clinical problem
Krzysztof Skowron, Nicolaus Copernicus University in Torun, Poland
Title : Challenges in implementing infection prevention and control guidelines among nurses during the COVID-19 pandemic: Insights from Nepal
Deepti KC, Glasgow Caledonian University, United Kingdom